Creo Medical Group FY22 results and recent funding - Proactive Research Analyst | News Direct

Creo Medical Group FY22 results and recent funding - Proactive Research Analyst

Creo Medical Group PLC
News release by Creo Medical Group PLC

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | April 28, 2023 03:00 AM Eastern Daylight Time

 

Proactive Research Analyst John Savin gives the highlights from his latest research note on UK-based medical device company Creo Medical Group PLC (AIM:CREO). Savin talks about the company's recent performance and key products, before moving on to look at how it is positioned for the future. He also touches on a recent placing that generated a net £32 million.

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com